Nasdaq Composite ($NASX)

As Parker-Hannifin has outperformed the Nasdaq over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Target has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.

Although Lowe’s has lagged the broader market over the past year, analysts continue to hold a constructive view on the stock’s forward outlook.

CSX Corporation has impressively outperformed the Nasdaq Composite over the past year, and analysts remain highly optimistic about the stock’s future.

McKesson shows strong relative performance, with analysts maintaining a bullish outlook on its stock.

Although Regeneron Pharmaceuticals has lagged the Nasdaq over the past year, analysts remain highly bullish about its prospects.

Warren Buffett's famous Berkshire shareholder meeting quote from 1979 warns about being complacent in one's investment practice. Here's what lessons investors should take away for today's market.

Altria Group has notably outperformed the Nasdaq recently, and analysts remain moderately optimistic about the stock’s prospects.

Though Bristol-Myers Squibb has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

This blue-chip stock is down 27% YTD but is bouncing back following Anthropic's announcement regarding AI.